Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells
Tazarotene-induced gene 1 (TIG1) encodes a protein that is a retinoid-regulated tumor suppressor. TIG1 is expressed in most normal tissues, and downregulation of TIG1 expression in multiple cancers is caused by promoter hypermethylation. Kazal-type serine protease inhibitor-2 (SPINK2) is a serine pr...
Main Authors: | Rong-Yaun Shyu, Chun-Hua Wang, Chang-Chieh Wu, Lu-Kai Wang, Mao-Liang Chen, Chan-Yen Kuo, Ming-Cheng Lee, Yi-Ying Lin, Fu-Ming Tsai |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2019/6171065 |
Similar Items
-
Characterization of Human Kazal-Type Serine Protease Inhibitor 2 and 4
by: Chun-Wei Chen, et al.
Published: (2007) -
Expression of Tazarotene-induced gene-1 (TIG1) in human cancer.
by: Hsiao-Ching, et al.
Published: (2010) -
MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E‐mutant colorectal adenocarcinoma
by: Kati Räsänen, et al.
Published: (2018-02-01) -
Serine peptidase inhibitor, Kazal type 1 (SPINK1) as a novel effector of cadherin-17 (CDH 17)/beta-catenin axis in hepatocellular carcinoma
by: Shek, Ho-ping, et al.
Published: (2014) -
Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth
by: Tsai Fu-Ming, et al.
Published: (2011-11-01)